We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > systemic lupus erythematosus

News List

UCB and Biogen's lupus drug falls short at Phase 2b pharmafile
October 25, 2018
The partnership of UCB and Biogen announced disappointing news, confirming that its experimental therapy dapirolizumab pegol (DZP) failed to meet its primary endpoint in the treatment...
STELARA Shows Positive Results In Treatment of Systemic Lupus Erythematosus americanpharmaceuticacreview
November 07, 2017
Based on the results of the Phase 2 study results, Janssen plans to advance STELARA into a Phase 3 SLE development program in 2018.
GSK’s Benlysta receives Japanese MHLW approval for systemic lupus erythematosus pharmaceufical-technology
September 30, 2017
Indicated for patients who are inadequate responders to existing therapies, Benlysta is approved for use as an add-on therapy in autoantibody-positive SLE patients.